Insider Julie Sweet plans 1,694-share sale at Accenture (NYSE: ACN)

Rhea-AI Filing Summary

Julie Sweet has filed a Form 144 to sell up to 1,694 Class A Ordinary shares. The planned sale is to be executed through UBS Financial Services on the NYSE, with an aggregate market value of $468,577.34. The issuer has 660,432,542 shares outstanding, providing context for the size of this transaction.

The shares to be sold were acquired as stock awards from the issuer, including 158 shares on 11/14/2025 and 1,536 shares on 01/05/2026. Over the past three months, Julie Sweet has already sold Class A Ordinary shares in several transactions, including 9,000 shares for gross proceeds of $2,246,165.10, 9,000 shares for $2,280,587.40, and 5,917 shares for $1,459,276.57. By signing the notice, the seller represents that she does not know of any undisclosed material adverse information about the issuer’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Ordinary	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	1694	468577.34	660432542	01/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Ordinary	11/14/2025	Stock Award	Issuer			158	11/14/2025	N/A
Class A Ordinary	01/05/2026	Stock Award	Issuer			1536	01/05/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Julie Sweet 1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN L2 D2	Class A Ordinary	10/22/2025	9000	2246165.10
Julie Sweet 1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN L2 D2	Class A Ordinary	10/29/2025	9000	2280587.40
Julie Sweet 1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN L2 D2	Class A Ordinary	11/05/2025	5917	1459276.57

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for ACN disclose about Julie Sweet?

The Form 144 discloses that Julie Sweet intends to sell up to 1,694 Class A Ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of $468,577.34.

How many Accenture (ACN) shares is Julie Sweet planning to sell under this Form 144?

The notice states a planned sale of 1,694 Class A Ordinary shares with an aggregate market value of $468,577.34.

When and how did Julie Sweet acquire the ACN shares reported on this Form 144?

The securities to be sold were acquired as stock awards from the issuer, including 158 shares on 11/14/2025 and 1,536 shares on 01/05/2026.

What prior sales of Accenture (ACN) shares has Julie Sweet made in the last three months?

The filing lists prior sales of 9,000 Class A Ordinary shares on 10/22/2025 for gross proceeds of $2,246,165.10, 9,000 shares on 10/29/2025 for $2,280,587.40, and 5,917 shares on 11/05/2025 for $1,459,276.57.

How large is Julie Sweet’s planned Form 144 sale compared with Accenture (ACN) shares outstanding?

The Form 144 notes that the issuer has 660,432,542 shares outstanding, against which the planned 1,694-share sale is measured.

What representation does the seller make about material information in this Form 144 for ACN?

By signing the notice, the seller represents that she does not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Does the Form 144 mention Rule 10b5-1 trading plans for the ACN shares?

The form provides a field for a Date of Plan Adoption or Giving of Instruction, if relying on Rule 10b5-1, and explains that by signing and indicating such a date, the person makes the required representation as of that date.